Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.83)
# 674
Out of 5,241 analysts
504
Total ratings
40.9%
Success rate
12.04%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NPCE NeuroPace | Maintains: Buy | $19 → $20 | $15.36 | +30.21% | 3 | May 15, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterates: Buy | $10 | $3.72 | +168.82% | 6 | May 14, 2026 | |
| OCS Oculis Holding AG | Maintains: Buy | $44 → $47 | $30.29 | +55.17% | 20 | May 12, 2026 | |
| DRTS Alpha Tau Medical | Maintains: Buy | $12 → $15 | $10.36 | +44.79% | 24 | May 12, 2026 | |
| TEM Tempus AI | Maintains: Buy | $95 → $64 | $43.93 | +45.69% | 5 | May 11, 2026 | |
| AXGN Axogen | Maintains: Buy | $39 → $50 | $40.99 | +21.98% | 4 | Apr 29, 2026 | |
| BLTE Belite Bio | Reiterates: Buy | $200 | $143.00 | +39.86% | 26 | Apr 22, 2026 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $7 → $2.5 | $0.64 | +290.02% | 2 | Apr 17, 2026 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $21 | $9.16 | +129.26% | 31 | Apr 13, 2026 | |
| BNGO Bionano Genomics | Maintains: Buy | $7 → $6 | $1.15 | +421.74% | 4 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.26 | - | 7 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $20 | $2.00 | +900.00% | 5 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.5 | $0.65 | +286.40% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3.5 | $1.17 | +199.15% | 8 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $31.21 | +124.29% | 9 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.5 | $0.97 | +469.95% | 3 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $4.33 | +130.95% | 12 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $23.21 | +59.41% | 1 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $5.72 | +424.48% | 16 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $30 | $12.35 | +142.91% | 24 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $16.09 | +24.30% | 21 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $21.06 | +70.94% | 7 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 → $1 | $0.15 | +551.47% | 2 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $39 → $50 | $27.21 | +83.76% | 9 | Dec 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $20.76 | +54.14% | 5 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $1.5 | $0.59 | +153.29% | 8 | Dec 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.29 | - | 24 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.68 | +488.58% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $13.05 | -61.69% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.23 | +987.90% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.93 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.57 | +345.86% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.82 | +148.23% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.50 | +300.00% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.80 | +136.84% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.61 | +121.61% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $10.77 | +48.56% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $19.97 | +25.19% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.10 | +172.73% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.11 | +1,321.80% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $0.83 | +60,119.20% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $34 | $4.54 | +648.90% | 7 | Jul 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $10.07 | +376.66% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $137.68 | -86.20% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.59 | - | 2 | Apr 16, 2020 |
NeuroPace
May 15, 2026
Maintains: Buy
Price Target: $19 → $20
Current: $15.36
Upside: +30.21%
Orchestra BioMed Holdings
May 14, 2026
Reiterates: Buy
Price Target: $10
Current: $3.72
Upside: +168.82%
Oculis Holding AG
May 12, 2026
Maintains: Buy
Price Target: $44 → $47
Current: $30.29
Upside: +55.17%
Alpha Tau Medical
May 12, 2026
Maintains: Buy
Price Target: $12 → $15
Current: $10.36
Upside: +44.79%
Tempus AI
May 11, 2026
Maintains: Buy
Price Target: $95 → $64
Current: $43.93
Upside: +45.69%
Axogen
Apr 29, 2026
Maintains: Buy
Price Target: $39 → $50
Current: $40.99
Upside: +21.98%
Belite Bio
Apr 22, 2026
Reiterates: Buy
Price Target: $200
Current: $143.00
Upside: +39.86%
Vivos Therapeutics
Apr 17, 2026
Maintains: Buy
Price Target: $7 → $2.5
Current: $0.64
Upside: +290.02%
Ocular Therapeutix
Apr 13, 2026
Reiterates: Buy
Price Target: $21
Current: $9.16
Upside: +129.26%
Bionano Genomics
Apr 13, 2026
Maintains: Buy
Price Target: $7 → $6
Current: $1.15
Upside: +421.74%
Apr 6, 2026
Downgrades: Neutral
Price Target: n/a
Current: $2.26
Upside: -
Apr 2, 2026
Maintains: Buy
Price Target: $30 → $20
Current: $2.00
Upside: +900.00%
Mar 31, 2026
Initiates: Buy
Price Target: $2.5
Current: $0.65
Upside: +286.40%
Mar 31, 2026
Maintains: Buy
Price Target: $4 → $3.5
Current: $1.17
Upside: +199.15%
Mar 19, 2026
Reiterates: Buy
Price Target: $70
Current: $31.21
Upside: +124.29%
Mar 16, 2026
Reiterates: Buy
Price Target: $5.5
Current: $0.97
Upside: +469.95%
Mar 11, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $4.33
Upside: +130.95%
Mar 10, 2026
Initiates: Buy
Price Target: $37
Current: $23.21
Upside: +59.41%
Mar 9, 2026
Maintains: Buy
Price Target: $32 → $30
Current: $5.72
Upside: +424.48%
Mar 5, 2026
Maintains: Buy
Price Target: $23 → $30
Current: $12.35
Upside: +142.91%
Feb 23, 2026
Maintains: Buy
Price Target: $17 → $20
Current: $16.09
Upside: +24.30%
Jan 26, 2026
Reiterates: Buy
Price Target: $36
Current: $21.06
Upside: +70.94%
Jan 9, 2026
Reiterates: Buy
Price Target: $3 → $1
Current: $0.15
Upside: +551.47%
Dec 30, 2025
Maintains: Buy
Price Target: $39 → $50
Current: $27.21
Upside: +83.76%
Dec 29, 2025
Reiterates: Buy
Price Target: $32
Current: $20.76
Upside: +54.14%
Dec 26, 2025
Maintains: Buy
Price Target: $4 → $1.5
Current: $0.59
Upside: +153.29%
Nov 24, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.29
Upside: -
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.68
Upside: +488.58%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $13.05
Upside: -61.69%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.23
Upside: +987.90%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.93
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $1.57
Upside: +345.86%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $2.82
Upside: +148.23%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.50
Upside: +300.00%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $3.80
Upside: +136.84%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $3.61
Upside: +121.61%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $10.77
Upside: +48.56%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $19.97
Upside: +25.19%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.10
Upside: +172.73%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.11
Upside: +1,321.80%
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $0.83
Upside: +60,119.20%
Jul 8, 2022
Downgrades: Neutral
Price Target: $30 → $34
Current: $4.54
Upside: +648.90%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $10.07
Upside: +376.66%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $137.68
Upside: -86.20%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.59
Upside: -